Thalidomide Pharmion Trademark Details

Thalidomide Pharmion was registered on Tuesday, September 15, 2009 and is currently owned by Celgene Corporation under the registration number 3682051 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, April 22, 2016, according to the United State Patent & Trademark Office
Word Mark Thalidomide Pharmion
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 77470287
Registration Number 3682051
Status Date Friday, April 22, 2016
Filing Date Friday, April 22, 2016
Registration Date Tuesday, September 15, 2009
Attorney Camille M. Miller

Correspondent

CAMILLE M. MILLER
COZEN O'CONNOR
One Liberty Place
1650 MARKET ST
PHILADELPHIA PA 19103

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Thalidomide"
Description of Mark The mark consists of the words "THALIDOMIDE PHARMION" appearing in black letters to the right.
Goods & Services Pharmaceutical Preparations Used to Treat Cancers and Immune Related Diseases

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, April 22, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.